Self-nanoemulsifying drug delivery systems (SNEDDS) of anti-cancer drugs: a multifaceted nanoplatform for the enhancement of oral bioavailability

References

• Ferlay J, Colombet M, Soerjomataram I, et al. Cancer statistics for the year 2020: an overview. Int J Cancer. 2021;149(4):778–789.
   Google Scholar
• Freres P, Jerusalem G, Moonen M. Categories of anticancer treatments. Anti-cancer treatments and cardiotoxicity. Amsterdam, Netherlands: Elsevier; 2017. p. 7–11.
   Google Scholar
• Benjamin B. Cytotoxic drugs. Introduction to basics of pharmacology and toxicology. Singapore: Springer Singapore; 2021. p. 1077–1090.
   Google Scholar
• Tran P, Pyo YC, Kim DH, et al. Overview of the manufacturing methods of solid dispersion technology for improving the solubility of poorly Water-Soluble drugs and application to anticancer drugs. Pharmaceutics. 2019;11(3):132.
   PubMed Web of Science ®Google Scholar
• Borner M, Scheithauer W, Twelves C, et al. Answering patients’ needs: oral alternatives to intravenous therapy. The Oncologist. 2001;6(S4):12–16.
   PubMedGoogle Scholar
• Fallowfield L, Atkins L, Catt S, et al. Patients’ preference for administration of endocrine treatments by injection or tablets: results from a study of women with breast cancer. Ann Oncol. 2006;17(2):205–210.
   PubMed Web of Science ®Google Scholar
• Rogala BG, Charpentier MM, Nguyen MK, et al. Oral anticancer therapy: management of drug interactions. J Oncol Pract. 2019;15(2):81–90.
   PubMed Web of Science ®Google Scholar
• Shinde P, Badgujar HF, Kumar U. Strategies to improve oral delivery of natural anticancer molecules. Emerging trends in nanomedicine. Singapore: Springer Singapore; 2021. p. 25–50.
   Google Scholar
• Zhang RX, Dong K, Wang Z, et al. Nanoparticulate drug delivery strategies to address intestinal cytochrome P450 CYP3A4 metabolism towards personalized medicine. Pharmaceutics. 2021;13(8):1261.
   PubMed Web of Science ®Google Scholar
• Zhang H, Xu H, Ashby CR, et al. Chemical molecular‐based approach to overcome multidrug resistance in cancer by targeting P‐glycoprotein (P‐gp). Med Res Rev. 2021;41(1):525–555.
   PubMed Web of Science ®Google Scholar
• van der Merwe J, Steenekamp J, Steyn D, et al. The role of functional excipients in solid oral dosage forms to overcome poor drug dissolution and bioavailability. Pharmaceutics. 2020;12(5):393.
   PubMed Web of Science ®Google Scholar
• Jain AK, Jain S. Advances in oral delivery of anti-cancer prodrugs. Expert Opin Drug Deliv. 2016;13(12):1759–1775.
   PubMed Web of Science ®Google Scholar
• Thanki K, Gangwal RP, Sangamwar AT, et al. Oral delivery of anticancer drugs: challenges and opportunities. J Control Release. 2013;170(1):15–40.
   PubMed Web of Science ®Google Scholar
• Mei L, Zhang Z, Zhao L, et al. Pharmaceutical nanotechnology for oral delivery of anticancer drugs. Adv Drug Deliv Rev. 2013;65(6):880–890.
   PubMed Web of Science ®Google Scholar
• Kumar S, Dilbaghi N, Saharan R, et al. Nanotechnology as emerging tool for enhancing solubility of poorly Water-Soluble drugs. BioNanoSci. 2012;2(4):227–250.
   Google Scholar
• Malaviya P, Shukal D, Vasavada AR. Nanotechnology-based drug delivery, metabolism and toxicity. Curr Drug Metab. 2019;20(14):1167–1190.
   PubMed Web of Science ®Google Scholar
• Zhang N., Zhang.   How nanotechnology can enhance docetaxel therapy. Int J Nanomedicine. 2013;8:2927–2941.
   PubMed Web of Science ®Google Scholar
• Kou L, Sun R, Bhutia YD, et al. Emerging advances in P-glycoprotein inhibitory nanomaterials for drug delivery. Expert Opin Drug Deliv. 2018;15(9):869–879.
   PubMed Web of Science ®Google Scholar
• Bhandari R, Kaur IP. Pharmacokinetics, tissue distribution and relative bioavailability of isoniazid-solid lipid nanoparticles. Int J Pharm. 2013;441(1–2):202–212.
   PubMed Web of Science ®Google Scholar
• Nguyen TX, Huang L, Gauthier M, et al. Recent advances in liposome surface modification for oral drug delivery. Nanomedicine (Lond). 2016;11(9):1169–1185.
   PubMed Web of Science ®Google Scholar
• Parhi P, Mohanty C, Sahoo SK. Nanotechnology-based combinational drug delivery: an emerging approach for cancer therapy. Drug Discov Today. 2012;17(17–18):1044–1052.
   PubMed Web of Science ®Google Scholar
• Gupta M, Sharma V, Chauhan NS. Nanotechnology for oral delivery of anticancer drugs: an insight potential. Nanostructures for oral medicine. Amsterdam, Netherlands: Elsevier; 2017. p. 467–510.
   Google Scholar
• Shahbazi MA, Santos H. Improving oral absorption via Drug-Loaded nanocarriers: absorption mechanisms, intestinal models and rational fabrication. Current Drug Metabolism. 2013;14(1):28–56.
   PubMed Web of Science ®Google Scholar
• Cherniakov I, Domb AJ, Hoffman A. Self-nano-emulsifying drug delivery systems: an update of the biopharmaceutical aspects. Expert Opin Drug Deliv. 2015;12(7):1121–1133.
   PubMed Web of Science ®Google Scholar
• Alshahrani SM, Alshetaili AS, Alalaiwe A, et al. Anticancer efficacy of self-nanoemulsifying drug delivery system of sunitinib malate. AAPS PharmSciTech. 2018;19(1):123–133.
   PubMed Web of Science ®Google Scholar
• Mazzaferro S, Bouchemal K, Ponchel G. Oral delivery of anticancer drugs I: general considerations. Drug Discov Today. 2013;18(1–2):25–34.
   PubMed Web of Science ®Google Scholar
• B. Shekhawat P, B. Pokharkar V. Understanding peroral absorption: regulatory aspects and contemporary approaches to tackling solubility and permeability hurdles. Acta Pharm Sin B. 2017;7(3):260–280.
   PubMed Web of Science ®Google Scholar
• Ghadi R, Dand N. BCS class IV drugs: highly notorious candidates for formulation development. J Control Release. 2017;248:71–95.
   PubMed Web of Science ®Google Scholar
• Pharmacokinetic considerations and challenges in oral anticancer drug therapy. Pharm J. 2019;11(6):1–14.
   Google Scholar
• Dey M, Das M, Chowhan A, et al. Breaking the barricade of oral chemotherapy through polysaccharide nanocarrier. Int J Biol Macromol. 2019;130:34–49.
   PubMed Web of Science ®Google Scholar
• Singh B, Bandopadhyay S, Kapil R, et al. Self-Emulsifying drug delivery systems (SEDDS): formulation development, characterization, and applications. Crit Rev Ther Drug Carrier Syst. 2009;26(5):427–521.
   PubMed Web of Science ®Google Scholar
• Shakeel F, Iqbal M, Ezzeldin E. Bioavailability enhancement and pharmacokinetic profile of an anticancer drug ibrutinib by self-nanoemulsifying drug delivery system. J Pharm Pharmacol. 2016;68(6):772–780.
   PubMed Web of Science ®Google Scholar
• Nanjwade BK, Patel DJ, Udhani RA, et al. Functions of lipids for enhancement of oral bioavailability of poorly Water-Soluble drugs. Sci Pharm. 2011;79(4):705–727.
   PubMedGoogle Scholar
• Solans C, Morales D, Homs M. Spontaneous emulsification. Curr Opin Colloid Interface Sci. 2016;22:88–93.
   Web of Science ®Google Scholar
• Agrawal S, Giri TK, Tripathi DK, et al. A review on novel therapeutic strategies for the enhancement of solubility for hydrophobic drugs through lipid and surfactant based self micro emulsifying drug delivery system: a novel approach. Am J Drug Discov Dev. 2012;2(4):143–183.
   Google Scholar
• Solè I, Solans C, Maestro A, et al. Study of nano-emulsion formation by dilution of microemulsions. J Colloid Interface Sci. 2012;376(1):133–139.
   PubMedGoogle Scholar
• Shafiq S, Shakeel F, Talegaonkar S, et al. Development and bioavailability assessment of ramipril nanoemulsion formulation. Eur J Pharm Biopharm. 2007;66(2):227–243.
   PubMed Web of Science ®Google Scholar
• Khan AW, Kotta S, Ansari SH, et al. Potentials and challenges in self-nanoemulsifying drug delivery systems. Expert Opin Drug Deliv. 2012;9(10):1305–1317.
   PubMed Web of Science ®Google Scholar
• Chime SA. Nanoemulsions—advances in formulation, characterization and applications in drug delivery. 2014;3:77–126.
   Google Scholar
• Date AA, Desai N, Dixit R, et al. Self-nanoemulsifying drug delivery systems: formulation insights, applications and advances. Nanomedicine (Lond). 2010;5(10):1595–1616.
   PubMed Web of Science ®Google Scholar
• Rehman FU, Shah KU, Shah SU, et al. From nanoemulsions to self-nanoemulsions, with recent advances in self-nanoemulsifying drug delivery systems (SNEDDS). Expert Opin Drug Deliv. 2017;14(11):1325–1340.
   PubMed Web of Science ®Google Scholar
• Kuruvila FS, Mathew F, Kuppuswamy S. Solid self nanoemulsifying drug delivery system (snedds) devolopment, applications and future perspective: a review. IAJPS. 2017;4:651–669.
   Google Scholar
• Parakh D. Self micro-emulsifying drug delivery system: approach to improve solubility and permeability. Int J Inst Pharm Life Sci. 2015;5:21–37.
   Google Scholar
• Maurya SD, Arya RK, Rajpal G, et al. Self-micro emulsifying drug delivery systems (SMEDDS): a review on physico-chemical and biopharmaceutical aspects. J Drug Delivery Ther. 2017;7(3):55.
   Google Scholar
• Gurram A, Deshpande P, Kar S, et al. Role of components in the formation of self-microemulsifying drug delivery systems. Indian J Pharm Sci. 2015;77(3):249–257.
   PubMed Web of Science ®Google Scholar
• Strickley RG. Solubilizing excipients in oral and injectable formulations. Pharm Res. 2004;21(2):201–230.
   PubMed Web of Science ®Google Scholar
• Odeberg JM, Kaufmann P, Kroon K-G, et al. Lipid drug delivery and rational formulation design for lipophilic drugs with low oral bioavailability, applied to cyclosporine. Eur J Pharm Sci. 2003;20(4–5):375–382.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Wang C, Chow AHL, et al. Self-nanoemulsifying drug delivery system (SNEDDS) for oral delivery of zedoary essential oil: formulation and bioavailability studies. Int J Pharm. 2010;383(1–2):170–177.
   PubMed Web of Science ®Google Scholar
• Hauss DJ, Fogal SE, Ficorilli J. V, et al. Lipid-based delivery systems for improving the bioavailability and lymphatic transport of a poorly water-soluble LTB4 inhibitor. J Pharm Sci. 1998;87(2):164–169.
   PubMed Web of Science ®Google Scholar
• Kimura M, Shizuki M, Miyoshi K, et al. Relationship between the molecular structures and emulsification properties of edible oils. Biosci Biotechnol Biochem. 1994;58(7):1258–1261.
   PubMed Web of Science ®Google Scholar
• Kassem AA, Marzouk MA, Ammar AA. Preparation and in vitro evaluation of self-nanoemulsifying drug delivery systems (SNEDDS) containing clotrimazole. Drug Discov Ther. 2010;4:373–379.
   PubMedGoogle Scholar
• Himaja M, Gupta V, Ankit KY. A review on self-nano-emulsifying drug delivery system. Int J Emerg Technol Innov Res. 2018;5:25–37.
   Google Scholar
• Murthy PN, Kumar Mahapatra A, Swadeep B, et al. Self-emulsifying drug delivery systems (SEDDS): an update from formulation development to therapeutic strategies. Int J PharmTech Res. 2014:6:546–568.
   Google Scholar
• Kaushik D. Recent developments in self-microemulsifying drug delivery system: an overview. Asian J Pharm. 2020;13:59–72.
   Web of Science ®Google Scholar
• Akiladevi D, Prakash H, Biju G, et al. Nano-novel approach: self nano emulsifying drug delivery system (SNEDDS)-review article. Res J Pharm Technol. 2020;13(2):983.
   Google Scholar
• Čerpnjak K, Zvonar A, Gašperlin M, et al. Lipid-based systems as promising approach for enhancing the bioavailability of poorly water-soluble drugs. Acta Pharm. 2013;63(4):427–445.
   PubMed Web of Science ®Google Scholar
• Gutiérrez JM, González C, Maestro A, et al. Nano-emulsions: new applications and optimization of their preparation. Curr Opin Colloid Interface Sci. 2008;13(4):245–251.
   Web of Science ®Google Scholar
• Rani S, Rana R, Saraogi GK, et al. Self-Emulsifying oral lipid drug delivery systems: advances and challenges. AAPS PharmSciTech. 2019;20(3):129.
   PubMed Web of Science ®Google Scholar
• Buckley ST, Frank KJ, Fricker G, et al. Biopharmaceutical classification of poorly soluble drugs with respect to “enabling formulations. Eur J Pharm Sci. 2013;50(1):8–16.
   PubMed Web of Science ®Google Scholar
• Chatterjee B, Hamed Almurisi S, Ahmed Mahdi Dukhan A, et al. Controversies with self-emulsifying drug delivery system from pharmacokinetic point of view. Drug Deliv. 2016;23(9):3639–3652.
   PubMed Web of Science ®Google Scholar
• Pouton CW. Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system. Eur J Pharm Sci. 2006;29(3–4):278–287.
   PubMed Web of Science ®Google Scholar
• Buya AB, Beloqui A, Memvanga PB, et al. Self-nano-emulsifying drug-delivery systems: from the development to the current applications and challenges in oral drug delivery. Pharmaceutics. 2020;12(12):1194.
   PubMed Web of Science ®Google Scholar
• Zhang L, Zhang L, Zhang M, et al. Self-emulsifying drug delivery system and the applications in herbal drugs. Drug Deliv. 2015;22(4):475–486.
   PubMed Web of Science ®Google Scholar
• Yoo J, Baskaran R, Yoo B-K. Self-Nanoemulsifying drug delivery system of lutein: physicochemical properties and effect on bioavailability of warfarin. Biomol Ther (Seoul). 2013;21(2):173–179.
   PubMed Web of Science ®Google Scholar
• Hao J, Fang X, Zhou Y, Wang J, Guo F, Li F, Peng X. Development and optimization of solid lipid nanoparticle formulation for ophthalmic delivery of chloramphenicol using a Box-Behnken design. Intern J Nanomed. 2011;683-92. 
   Google Scholar
• Keskin Gündoğdu T, Deniz İ, Çalışkan G, et al. Experimental design methods for bioengineering applications. Crit Rev Biotechnol. 2016;36(2):368–388.
   PubMed Web of Science ®Google Scholar
• Homayouni Rad A, Pirouzian HR, Toker OS, et al. Application of simplex lattice mixture design for optimization of sucrose-free milk chocolate produced in a ball mill. LWT. 2019;115:108435.
   Web of Science ®Google Scholar
• Cunha S, Costa CP, Moreira JN, et al. Using the quality by design (QbD) approach to optimize formulations of lipid nanoparticles and nanoemulsions: a review. Nanomedicine. 2020;28:102206.
   PubMed Web of Science ®Google Scholar
• de Aguiar PF, Bourguignon B, Khots MS, et al. D-optimal designs. Chemometr Intelligent Lab Syst. 1995;30(2):199–210.
   Web of Science ®Google Scholar
• Talekar SD, Haware R. V, Dave RH. Evaluation of self-nanoemulsifying drug delivery systems using multivariate methods to optimize permeability of captopril oral films. Eur J Pharm Sci. 2019;130:215–224.
   PubMed Web of Science ®Google Scholar
• Sharma G, Wilson K, van der Walle CF, et al. Microemulsions for oral delivery of insulin: design, development and evaluation in streptozotocin induced diabetic rats. Eur J Pharm Biopharm. 2010;76(2):159–169.
   PubMed Web of Science ®Google Scholar
• Goddeeris C, Cuppo F, Reynaers H, et al. Light scattering measurements on microemulsions: estimation of droplet sizes. Int J Pharm. 2006;312(1–2):187–195.
   PubMedGoogle Scholar
• Wang L, Dong J, Chen J, et al. Design and optimization of a new self-nanoemulsifying drug delivery system. J Colloid Interface Sci. 2009;330(2):443–448.
   PubMed Web of Science ®Google Scholar
• Chamieh J, Merdassi H, Rossi JC, et al. Size characterization of lipid-based self-emulsifying pharmaceutical excipients during lipolysis using Taylor dispersion analysis with fluorescence detection. Int J Pharm. 2018;537(1–2):94–101.
   PubMedGoogle Scholar
• Phillies GDJ. Interpretation of fluorescence correlation spectra of biopolymer solutions. Biopolymers. 2016;105(5):260–266.
   PubMed Web of Science ®Google Scholar
• Gershanik T, Benita S. Positively charged self-emulsifying oil formulation for improving oral bioavailability of progesterone. Pharm Dev Technol. 1996;1(2):147–157.
   PubMedGoogle Scholar
• Corbo DC, Liu JC, Chien YW. Characterization of the barrier properties of mucosal membranes. J Pharm Sci. 1990;79(3):202–206.
   PubMed Web of Science ®Google Scholar
• Netsomboon K, Bernkop-Schnürch A. Mucoadhesive vs. mucopenetrating particulate drug delivery. Eur J Pharm Biopharm. 2016;98:76–89.
   PubMed Web of Science ®Google Scholar
• Rajpoot K, Tekade M, Pandey V, et al. Self-microemulsifying drug-delivery system: ongoing challenges and future ahead. Drug delivery systems. Amsterdam, Netherlands: Elsevier; 2020. p. 393–454.
   Google Scholar
• Czajkowska-Kośnik A, Szekalska M, Amelian A, et al. Development and evaluation of liquid and solid Self-Emulsifying drug delivery systems for atorvastatin. Molecules. 2015;20(12):21010–21022.
   PubMed Web of Science ®Google Scholar
• Qian J, Meng H, Xin L, et al. Self-nanoemulsifying drug delivery systems of myricetin: formulation development, characterization, and in vitro and in vivo evaluation. Colloids Surf B Biointerfaces. 2017;160:101–109.
   PubMed Web of Science ®Google Scholar
• Patel J, Dhingani A, Garala K, et al. Quality by design approach for oral bioavailability enhancement of irbesartan by self-nanoemulsifying tablets. Drug Deliv. 2014;21(6):412–435.
   PubMed Web of Science ®Google Scholar
• Mandal S, Mandal SS. Microemulsion drug delivery system: a platform for improving dissolution rate of poorly water soluble drug. PCI- Approved-Ijpsn. 2011;3(4):1214–1219.
   Google Scholar
• Bali V, Ali M, Ali J. Study of surfactant combinations and development of a novel nanoemulsion for minimising variations in bioavailability of ezetimibe. Colloids Surf B Biointerfaces. 2010;76(2):410–420.
   PubMed Web of Science ®Google Scholar
• Vithani K, Jannin V, Pouton CW, et al. Colloidal aspects of dispersion and digestion of self-dispersing lipid-based formulations for poorly water-soluble drugs. Adv Drug Deliv Rev. 2019;142:16–34.
   PubMed Web of Science ®Google Scholar
• Rowley G. Filling of liquids and semi-solids into two piece hard capsules. In: Podczeck F, Jones B, editors. Pharmaceutical capsules. 2nd ed. London: Pharmaceutical Press; 2004. p. 169–194.
   Google Scholar
• Parikh KJ, Sawant KK. Solubilization of vardenafil HCl in lipid-based formulations enhances its oral bioavailability in vivo: a comparative study using tween - 20 and Cremophor - EL. J Mol Liq. 2019;277:189–199.
   Web of Science ®Google Scholar
• Gupta S, Chavhan S, Sawant KK. Self-nanoemulsifying drug delivery system for adefovir dipivoxil: design, characterization, in vitro and ex vivo evaluation. Colloids Surf A. 2011;392(1):145–155.
   Google Scholar
• Elsheikh MA, Elnaggar YSR, Gohar EY, et al. Nanoemulsion liquid preconcentrates for raloxifene hydrochloride: optimization and in vivo appraisal. Int J Nanomedicine. 2012;7:3787–3802.
   PubMed Web of Science ®Google Scholar
• Elnaggar YSR, El-Massik MA, Abdallah OY. Self-nanoemulsifying drug delivery systems of tamoxifen citrate: design and optimization. Int J Pharm. 2009;380(1–2):133–141.
   PubMed Web of Science ®Google Scholar
• Zhuang X, Tian X, Zheng Y, et al. Formulation and physicochemical characterisation of a novel Self-Microemulsifying delivery system as hydrotropic and solubilising agent for penfluridol. Procedia Eng. 2011;18:59–65.
   Google Scholar
• Xue X, Cao M, Ren L, et al. Preparation and optimization of rivaroxaban by self-nanoemulsifying drug delivery system (SNEDDS) for enhanced oral bioavailability and no food effect. AAPS PharmSciTech. 2018;19(4):1847–1859.
   PubMed Web of Science ®Google Scholar
• Woo JS, Song YK, Hong JY, et al. Reduced food-effect and enhanced bioavailability of a self-microemulsifying formulation of itraconazole in healthy volunteers. Eur J Pharm Sci. 2008;33(2):159–165.
   PubMed Web of Science ®Google Scholar
• Nepal PR, Han HK, Choi HK. Preparation and in vitro–in vivo evaluation of witepsol® H35 based self-nanoemulsifying drug delivery systems (SNEDDS) of coenzyme Q10. Eur J Pharm Sci. 2010;39(4):224–232.
   PubMed Web of Science ®Google Scholar
• Singh G, Pai RS. Trans -resveratrol self-nano-emulsifying drug delivery system (SNEDDS) with enhanced bioavailability potential: optimization, pharmacokinetics and in situ single pass intestinal perfusion (SPIP) studies. Drug Deliv. 2015;22(4):522–530.
   PubMed Web of Science ®Google Scholar
• Baloch J, Sohail MF, Sarwar HS, et al. Self-Nanoemulsifying drug delivery system (SNEDDS) for improved oral bioavailability of chlorpromazine: in vitro and in vivo evaluation. Medicina (B). 2019;55(5):210.
   PubMedGoogle Scholar
• Bhikshpathi DV. Formulation and optimization of fluvastatin loaded self-emulsifying drug delivery systems. Asian J Pharm. 2020;14(3):458–468.
   Web of Science ®Google Scholar
• Nazzal S, Khan MA. Controlled release of a self-emulsifying formulation from a tablet dosage form: stability assessment and optimization of some processing parameters. Int J Pharm. 2006;315(1–2):110–121.
   PubMedGoogle Scholar
• Gao P, Morozowich W. Development of supersaturatable self-emulsifying drug delivery system formulations for improving the oral absorption of poorly soluble drugs. Expert Opin Drug Deliv. 2006;3(1):97–110.
   PubMedGoogle Scholar
• Usmani A, Mishra A, Arshad M, et al. Development and evaluation of doxorubicin self nanoemulsifying drug delivery system with nigella sativa oil against human hepatocellular carcinoma. Artif Cells Nanomed Biotechnol. 2019;47(1):933–944.
   PubMed Web of Science ®Google Scholar
• Seo YG, Kim DH, Ramasamy T, et al. Development of docetaxel-loaded solid self-nanoemulsifying drug delivery system (SNEDDS) for enhanced chemotherapeutic effect. Int J Pharm. 2013;452(1–2):412–420.
   PubMed Web of Science ®Google Scholar
• Akhtartavan S, Karimi M, Karimian K, et al. Evaluation of a self-nanoemulsifying docetaxel delivery system. Biomed Pharmacother. 2019;109:2427–2433.
   PubMed Web of Science ®Google Scholar
• Sandhu PS, Beg S, Mehta F, et al. Novel dietary lipid-based self-nanoemulsifying drug delivery systems of paclitaxel with p-gp inhibitor: implications on cytotoxicity and biopharmaceutical performance. Expert Opin Drug Deliv. 2015;12(11):1809–1822.
   PubMed Web of Science ®Google Scholar
• Beg S, Kaur R, Khurana RK, et al. QbD-Based development of cationic self-nanoemulsifying drug delivery systems of paclitaxel with improved biopharmaceutical attributes. AAPS PharmSciTech. 2019;20(3):118.
   PubMed Web of Science ®Google Scholar
• Osman AAKZH. Enhancement of efficacy and reduced toxicity of cisplatin through self nanoemulsifying drug delivery system (SNEDDS). Int J Pharmacol. 2017;13:292–302.
   Google Scholar
• Khalid N, Sarfraz M, Arafat M, et al. Nano-sized droplets of self-emulsifying system for enhancing oral bioavailability of chemotherapeutic agent VP-16 in rats: a nano lipid carrier for BCS class IV drugs. J Pharm Pharm Sci. 2018;21(1):398–408.
   PubMedGoogle Scholar
• Nazari-Vanani R, Azarpira N, Heli H, et al. A novel self-nanoemulsifying formulation for sunitinib: evaluation of anticancer efficacy. Colloids Surf B Biointerfaces. 2017;160:65–72.
   PubMed Web of Science ®Google Scholar
• Nottingham E, Sekar V, Mondal A, et al. The role of Self-Nanoemulsifying drug delivery systems of CDODA-Me in sensitizing Erlotinib-Resistant non–small cell lung cancer. J Pharm Sci. 2020;109(6):1867–1882.
   PubMed Web of Science ®Google Scholar
• Heshmati N, Cheng X, Eisenbrand G, et al. Enhancement of oral bioavailability of E804 by Self-Nanoemulsifying drug delivery system (SNEDDS) in rats. J Pharm Sci. 2013;102(10):3792–3799.
   PubMed Web of Science ®Google Scholar
• Prajapati B. Bioavailability enhancement study of BCS class IV drug: snedds approach. Pharm Anal Acta. 2014.
   PubMedGoogle Scholar
• Kamel AO, Mahmoud AA. Enhancement of human oral bioavailability and & in vitro; antitumor activity of rosuvastatin via spray dried self-nanoemulsifying drug delivery system. J Biomed Nanotechnol. 2013;9(1):26–39.
   PubMed Web of Science ®Google Scholar
• Mahmoudian M, Valizadeh H, Löbenberg R, et al. Enhancement of the intestinal absorption of bortezomib by self-nanoemulsifying drug delivery system. Pharm Dev Technol. 2020;25(3):351–358.
   PubMed Web of Science ®Google Scholar
• Shim HJ, Hwang JE, Bae WK, et al. Abstract 2834: antitumor effect of AGM 130 (5’-OH-5-nitro-Indirubin oxime), a cyclin-dependent kinase inhibitor in colorectal cancer cells. Cancer Res. 2016;76(14):2834–2834.
   Google Scholar
• Jeevana JB, Sreelakshmi K. Design and evaluation of Self-Nanoemulsifying drug delivery system of flutamide. J Young Pharm. 2011;3(1):4–8.
   PubMedGoogle Scholar
• Shakeel F, Haq N, Al-Dhfyan A, et al. Double w/o/w nanoemulsion of 5-fluorouracil for self-nanoemulsifying drug delivery system. J Mol Liq. 2014;200:183–190.
   Web of Science ®Google Scholar
• Arya A, Ahmad H, Tulsankar S, et al. Bioflavonoid hesperetin overcome bicalutamide induced toxicity by co-delivery in novel SNEDDS formulations: optimization, in vivo evaluation and uptake mechanism. Mater Sci Eng C Mater Biol Appl. 2017;71:954–964.
   PubMed Web of Science ®Google Scholar
• Izgelov D, Cherniakov I, Aldouby Bier G, et al. The effect of piperine Pro-Nano lipospheres on direct intestinal phase II metabolism: the raloxifene paradigm of enhanced oral bioavailability. Mol Pharm. 2018;15(4):1548–1555.
   PubMedGoogle Scholar
• Jain AK, Thanki K, Jain S. Solidified Self-Nanoemulsifying formulation for oral delivery of combinatorial therapeutic regimen: part I. Formulation development, statistical optimization, and in vitro characterization. Pharm Res. 2014;31(4):923–945.
   PubMed Web of Science ®Google Scholar
• Zeng L, Zhang Y. Development, optimization and in vitro evaluation of norcantharidin loadedself-nanoemulsifying drug delivery systems (NCTD-SNEDDS). Pharm Dev Technol. 2017;22(3):399–408.
   PubMed Web of Science ®Google Scholar
• Shukla M, Jaiswal S, Sharma A, et al. A combination of complexation and self-nanoemulsifying drug delivery system for enhancing oral bioavailability and anticancer efficacy of curcumin. Drug Dev Ind Pharm. 2017;43(5):847–861.
   PubMed Web of Science ®Google Scholar
• Altamimi MA, Kazi M, Hadi Albgomi M, et al. Development and optimization of self-nanoemulsifying drug delivery systems (SNEDDS) for curcumin transdermal delivery: an anti-inflammatory exposure. Drug Dev Ind Pharm. 2019;45(7):1073–1078.
   PubMed Web of Science ®Google Scholar
• Ke Z, Hou X, Jia X. Design and optimization of self-nanoemulsifying drug delivery systems for improved bioavailability of cyclovirobuxine D. Drug Des Devel Ther. 2016;10:2049–2060.
   PubMed Web of Science ®Google Scholar
• Ahmad N, Ahmad R, Naqvi A, et al. Enhancement of quercetin oral bioavailability by self-nanoemulsifying drug delivery system and their quantification through ultra high performance liquid chromatography and mass spectrometry in cerebral ischemia. Drug Res (Stuttg). 2017;67(10):564–575.
   PubMed Web of Science ®Google Scholar
• Tran TH, Guo Y, Song D, et al. Quercetin-containing self-nanoemulsifying drug delivery system for improving oral bioavailability. J Pharm Sci. 2014;103(3):840–852.
   PubMed Web of Science ®Google Scholar
• Sharma S, Narang JK, Ali J, et al. Synergistic antioxidant action of vitamin E and rutin SNEDDS in ameliorating oxidative stress in a parkinson’s disease model. Nanotechnology. 2016;27(37):375101.
   PubMed Web of Science ®Google Scholar
• Yanfei M, Guoguang C, Lili R, et al. Controlled release of glaucocalyxin – a self-nanoemulsifying system from osmotic pump tablets with enhanced bioavailability. Pharm Dev Technol. 2017;22(2):148–155.
   PubMed Web of Science ®Google Scholar
• Kumar R, Khursheed R, Kumar R, et al. Self-nanoemulsifying drug delivery system of fisetin: formulation, optimization, characterization and cytotoxicity assessment. J Drug Deliv Sci Technol. 2019;54:101252.
   Web of Science ®Google Scholar
• Khan AW, Kotta S, Ansari SH, et al. Self-nanoemulsifying drug delivery system (SNEDDS) of the poorly water-soluble grapefruit flavonoid naringenin: design, characterization, in vitro and in vivo evaluation. Drug Deliv. 2015;22(4):552–561.
   PubMed Web of Science ®Google Scholar
• Izham MNM, Hussin Y, Rahim NFC, et al. Physicochemical characterization, cytotoxic effect and toxicity evaluation of nanostructured lipid carrier loaded with eucalyptol. BMC Complement Med Ther. 2021;21(1):254.
   PubMedGoogle Scholar
• Ujilestari T, Danar Dono N, Ariyadi B, et al. Formulation and characterization of self-nano emulsifying drug delivery systems of lemongrass (cymbopogon citratus) essential oil. Mal J Fund Appl Sci. 2018;14(3):360–363.
   Web of Science ®Google Scholar
• Wu GS, Lu JJ, Guo JJ, et al. Synergistic anti-cancer activity of the combination of dihydroartemisinin and doxorubicin in breast cancer cells. Pharmacol Rep. 2013;65(2):453–459.
   PubMed Web of Science ®Google Scholar
• Verweij J, Clavel M, Chevalier B. Paclitaxel (TaxolTM) and docetaxel (TaxotereTM): not simply two of a kind. Ann Oncol. 1994;5(6):495–505.
   PubMed Web of Science ®Google Scholar
• Ahn MY, Kim TH, Kwon SM, et al. 5-Nitro-5′-hydroxy-indirubin-3′-oxime (AGM130), an indirubin-3′-oxime derivative, inhibits tumor growth by inducing apoptosis against non-small cell lung cancer in vitro and in vivo. Eur J Pharm Sci. 2015;79:122–131.
   PubMed Web of Science ®Google Scholar
• Eng-Wong J, Zujewski JA. Raloxifene and its role in breast cancer prevention. Expert Rev Anticancer Ther. 2004;4(4):523–532.
   PubMedGoogle Scholar
• Khadka NK, Cheng X, Ho CS, et al. Interactions of the anticancer drug tamoxifen with lipid membranes. Biophys J. 2015;108(10):2492–2501.
   PubMed Web of Science ®Google Scholar
• Zhu L, Chen L. Progress in research on paclitaxel and tumor immunotherapy. Cell Mol Biol Lett. 2019;24:40.
   PubMed Web of Science ®Google Scholar
• Riddell IA, Lippard SJ. 1. Cisplatin and oxaliplatin: our current understanding of their actions. Berlin, Germany: Metallo-Drugs: Development and Action of Anticancer Agents. De Gruyter; 2018. p. 1–42.
   Google Scholar
• van Maanen JMS, Retel J, de Vries J, et al. Mechanism of action of antitumor drug etoposide: a review. J Natl Cancer Inst. 1988;80(19):1526–1533.
   PubMed Web of Science ®Google Scholar
• Ferrari SM, Centanni M, Virili C, et al. Sunitinib in the treatment of thyroid cancer. Curr Med Chem. 2019;26(6):963–972.
   PubMed Web of Science ®Google Scholar
• Paydas S. Management of adverse effects/toxicity of ibrutinib. Crit Rev Oncol Hematol. 2019;136:56–63.
   PubMed Web of Science ®Google Scholar
• Wu GY, Liu JZ, Fang FD, et al. Studies on the mechanism of indirubin action in the treatment of chronic granulocytic leukemia. V. Binding between indirubin and DNA and identification of the type of binding. Sci Sin B. 1982;25(10):1071–1079.
   PubMedGoogle Scholar
• Zhu J, Sun Y, Lu Y, et al. Glaucocalyxin a exerts anticancer effect on osteosarcoma by inhibiting GLI1 nuclear translocation via regulating PI3K/akt pathway. Cell Death Dis. 2018;9(6):708.
   PubMedGoogle Scholar
• Qiu P, Wang S, Liu M, et al. Norcantharidin inhibits cell growth by suppressing the expression and phosphorylation of both EGFR and c-Met in human Colon cancer cells. BMC Cancer. 2017;17(1):55.
   PubMedGoogle Scholar
• Elsayed I, El-Dahmy RM, El-Emam SZ, et al. Response surface optimization of biocompatible elastic nanovesicles loaded with rosuvastatin calcium: enhanced bioavailability and anticancer efficacy. Drug Deliv Transl Res. 2020;10(5):1459–1475.
   PubMed Web of Science ®Google Scholar
• Jiang F, Chen Y, Ren S, et al. Cyclovirobuxine D inhibits colorectal cancer tumorigenesis via the CTHRC1-AKT/ERK-Snail signaling pathway. Int J Oncol. 2020;57:183–196.
   PubMed Web of Science ®Google Scholar
• Tan CRC, Abdul-Majeed S, Cael B, et al. Clinical pharmacokinetics and pharmacodynamics of bortezomib. Clin Pharmacokinet. 2019;58(2):157–168.
   PubMed Web of Science ®Google Scholar
• Sarrabay A, Hilmi C, Tinwell H, et al. Low dose evaluation of the antiandrogen flutamide following a mode of action approach. Toxicol Appl Pharmacol. 2015;289(3):515–524.
   PubMed Web of Science ®Google Scholar
• Osguthorpe DJ, Hagler AT. Mechanism of androgen receptor antagonism by bicalutamide in the treatment of prostate cancer. Biochemistry. 2011;50(19):4105–4113.
   PubMed Web of Science ®Google Scholar
• Jiang M, Zhu M, Wang L, et al. Anti-tumor effects and associated molecular mechanisms of myricetin. Biomed Pharmacother. 2019;120:109506.
   PubMed Web of Science ®Google Scholar
• Imran M, Saeed F, Gilani SA, et al. Fisetin: an anticancer perspective. Food Sci Nutr. 2021;9(1):3–16.
   PubMed Web of Science ®Google Scholar
• Balusamy SR, Perumalsamy H, Veerappan K, et al. Citral induced apoptosis through modulation of key genes involved in fatty acid biosynthesis in human prostate cancer cells: in silico and in vitro study. BioMed Res Int. 2020;2020:1–15.
   Web of Science ®Google Scholar
• Zhang YJ, Zhang MF, Zhou HF, et al. Activation of c-Jun/JNK signaling predicts poor prognosis in nasopharyngeal carcinoma. Int J Clin Exp Pathol. 2018;11:2699–2706.
   PubMed Web of Science ®Google Scholar
• Giordano T. Curcumin and cancer. Nutrients. 2019;11(10):2376.
   PubMed Web of Science ®Google Scholar
• Nazari-Vanani R, Moezi L, Heli H. In vivo evaluation of a self-nanoemulsifying drug delivery system for curcumin. Biomed Pharmacother. 2017;88:715–720.
   PubMed Web of Science ®Google Scholar
• Rauf A, Imran M, Khan IA, et al. Anticancer potential of quercetin: a comprehensive review. Phytother Res. 2018;32(11):2109–2130.
   PubMed Web of Science ®Google Scholar
• Tripathi S, Kushwah V, Thanki K, et al. Triple antioxidant SNEDDS formulation with enhanced oral bioavailability: implication of chemoprevention of breast cancer. Nanomedicine. 2016;12(6):1431–1443.
   PubMed Web of Science ®Google Scholar
• Pangeni R, Panthi V, Yoon I-S, et al. Preparation, characterization, and in vivo evaluation of an oral multiple nanoemulsive system for Co-Delivery of pemetrexed and quercetin. Pharmaceutics. 2018;10(3):158.
   PubMed Web of Science ®Google Scholar
• Caparica R, Júlio A, Araújo MEM, et al. Anticancer activity of rutin and its combination with ionic liquids on renal cells. Biomolecules. 2020;10(2):233.
   PubMed Web of Science ®Google Scholar
• Memariani Z, Abbas SQ, Ul Hassan SS, et al. Naringin and naringenin as anticancer agents and adjuvants in cancer combination therapy: efficacy and molecular mechanisms of action, a comprehensive narrative review. Pharmacol Res. 2021;171:105264.
   PubMed Web of Science ®Google Scholar
• Casey SC, Amedei A, Aquilano K, et al. Cancer prevention and therapy through the modulation of the tumor microenvironment. Semin Cancer Biol. 2015;35:s199–S223.
   PubMed Web of Science ®Google Scholar